Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 622Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Sumitomo Pharma Canada, Inc.

02 4Sunovion Pharmaceuticals Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Sunovion Pharmaceuticals Can...

arrow
2024 ACI Convention
Not Confirmed

Sunovion Pharmaceuticals Canada Inc.

Country
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name : APTIOM

Patent Number : 2180301

Filing Date : 1996-07-02

Strength per Unit : 200 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2016-07-02

Date Granted : 2004-02-10

blank

02

Sunovion Pharmaceuticals Can...

arrow
2024 ACI Convention
Not Confirmed

Sunovion Pharmaceuticals Canada Inc.

Country
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name : APTIOM

Patent Number : 2180301

Filing Date : 1996-07-02

Strength per Unit : 400 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2016-07-02

Date Granted : 2004-02-10

blank

03

Sunovion Pharmaceuticals Can...

arrow
2024 ACI Convention
Not Confirmed

Sunovion Pharmaceuticals Canada Inc.

Country
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name : APTIOM

Patent Number : 2180301

Filing Date : 1996-07-02

Strength per Unit : 600 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2016-07-02

Date Granted : 2004-02-10

blank

04

Sunovion Pharmaceuticals Can...

arrow
2024 ACI Convention
Not Confirmed

Sunovion Pharmaceuticals Canada Inc.

Country
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name : APTIOM

Patent Number : 2180301

Filing Date : 1996-07-02

Strength per Unit : 800 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2016-07-02

Date Granted : 2004-02-10

blank

05

Sumitomo Pharma Canada, Inc.

arrow
2024 ACI Convention
Not Confirmed

Sumitomo Pharma Canada, Inc.

Country
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name : APTIOM

Patent Number : 2607427

Filing Date : 2005-05-06

Strength per Unit : 200 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-05-06

Date Granted : 2015-11-24

blank

06

Sumitomo Pharma Canada, Inc.

arrow
2024 ACI Convention
Not Confirmed

Sumitomo Pharma Canada, Inc.

Country
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name : APTIOM

Patent Number : 2607427

Filing Date : 2005-05-06

Strength per Unit : 400 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-05-06

Date Granted : 2015-11-24

blank

07

Sumitomo Pharma Canada, Inc.

arrow
2024 ACI Convention
Not Confirmed

Sumitomo Pharma Canada, Inc.

Country
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name : APTIOM

Patent Number : 2607427

Filing Date : 2005-05-06

Strength per Unit : 600 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-05-06

Date Granted : 2015-11-24

blank

08

Sumitomo Pharma Canada, Inc.

arrow
2024 ACI Convention
Not Confirmed

Sumitomo Pharma Canada, Inc.

Country
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name : APTIOM

Patent Number : 2607427

Filing Date : 2005-05-06

Strength per Unit : 800 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-05-06

Date Granted : 2015-11-24

blank